Scientific Committees
Scientific Steering Committee
(former MDSC)
Outcome of discussions
Safety of milk
with regard to TSE: State of affairs
1. Summary
a. Because of the recent evidence of BSE
being present in a number of countries where it had not
been detected until recently, Commission services are
frequently invited to express their opinion on the security
status of ruminant milk as a possible source of TSE
infectivity.
b. The experimental evidence so far of
bovine milk being safe with regard to BSE risk has been
questioned because these experiments were carried out on
mice; it was considered
1
that these tests may have underestimated
any possible risk because of the species barrier from cows to
mice. It is noted that milk had the potential to transmit
prion diseases like BSE because it contains a significant
component of leucocytes.
The Commission services therefore
invited the Scientific Steering Committee (SSC) to prepare
a state of affairs regarding the available knowledge and
evidence on the safety of milk with regard to TSE
risk.
On the basis of the discussion of a
report prepared by the TSE/BSE
ad hoc Group, the Scientific Steering Committee
(SSC) considers that the conclusions of the Scientific
Veterinary Committee (E.C., 1996), the Multidisciplinary
Scientific Committee (E.C., 1997) and itself (E.C., 1999),
remain valid and that the evidence available to date does
not point at milk or colostrum representing a possible
risk. The SSC also supports the recommendation that for
precautionary reasons the milk, colostrum or milk products
from suspect BSE cases should not be offered for
consumption.
No final results of further experiments
became recently available and the SSC confirms the
recommendations for research made in each of the previously
listed scientific opinions.
2. Report from the TSE/BSE ad hoc Group
The TSE/BSE
ad hoc Group reviewed the information and evidence
available to date. The state-of-affairs report prepared at
its meeting of 15 March 2001 on the basis of contributions
from various scientists (see section 3) is presented
hereafter.
2.1 The Report of the Scientific Veterinary Committee
of 1996 (E.C., 1997)
In its opinion of 1996, the Scientific
Veterinary Committee, "having examined the considerable
epidemiological and infectivity data pertaining to BSE,
maternal transmission and milk, concludes that bovine milk
from healthy cows and products derived therefrom which
contain no animal-derived additives can be safely consumed
in any form by any species. There is no evidence that milk
transmits BSE and the Committee considers any risk from
milk to be negligible".
"In regard to colostrum, [the Committee]
regarded any risks to be negligible." It further
recommended a "Prohibition on the use of milk (or
colostrum) or any product derived from these commodities
from any cow clinically suspected to have BSE for any
nutritional or other purpose. An exception for the
suspect's own
calf can be made" (...).
2.2. The scientific opinion of the Multidisciplinary
Scientific Committee of 1997 (Will, 1997, E.C.,
1997b).
The evidence contained in the full
report of the Scientific Veterinary Committee (E.C., 1996)
was reviewed in 1997 by the Multidisciplinary Scientific
Committee (Will, 1997; E.C., 1997) that concurred with the
1996 conclusions.
A maternal cohort study provided
statistical evidence of a maternal risk enhancement (e.g.,
Donnelly
et al, 1997
a, b)
2
, but did not provide evidence on the
risk of transmission by milk as the calves in this study
received only colostrum from their dams and as other
explanations than vertical transmission (for example
peri-natal conditions) could not be excluded.
A serious hint that milk does not
transmit the disease was the beef suckler study (Wilesmith
and Ryan, 1997, 1998; Donnelly, 1998) where no cases were
reported although all of them received colostrum and
milk.
2.3. The SSC opinion on vertical transmission
(1999)
In its opinion of 18-19 March 1999 on
The possible vertical transmission of Bovine Spongiform
Encephalopathy (BSE), the SSC referred as follows to the
work of the UK Spongiform Encephalopathy Advisory Committee
(SEAC):
"As regards the risks from bovine milk,
the Scientific Steering Committee refers to the continuous
review by the UK Spongiform Encephalopathy Advisory
Committee (SEAC). SEAC has regularly discussed the safety
of bovine milk in regard to BSE, the last time on 9
November 1998. The latest substantive SEAC view, expressed
on 16 April 1997, was that the measures currently in place
to protect the consumer were considered appropriate. (UK
law states that milk derived from BSE affected cattle or
cattle suspected to have BSE shall not be sold, supplied or
used for human or animal consumption, with the exception
that it may be fed to the cow's own calf.) SEAC concluded
then (16/4/97) that no evidence had been found to suggest
that milk from any species affected by transmissible
spongiform encephalopathies was infectious. The Committee
is keeping the possible risk infectivity in milk under
review and stated most recently on 14 May 1998 that there
was no reason to change their previous advice on the safety
of milk. This advice may need to be updated as new data and
information become available.
However, the Scientific Steering
Committee notes that, in the absence of any infectivity
studies on semen, embryos, fetal tissue, milk and colostrum
by i/c inoculation of the homologous species in bovines,
ovines and caprines, and in the absence of all the
necessary experimental and epidemiological data as detailed
in the report, precise estimates of these risks cannot be
made."
2.4. Summary of presently available evidence (March
2001):
a. To date, the infectious agent has not
been detected by mice bioassay of milk from humans with kuru
or CJD or from cattle with BSE
3
or sheep with scrapie.
b. To date, no mother to child
transmissions have occurred in any animal species used in
experimental studies (including primates).
c. One single case has been reported on
in 1992 of a 38-year-old pregnant woman with sporadic CJD
whose colostrum was found to be infected when injected i/c
into mice (Tamai et al, 1992). However, following further
morphological examination of fixed mouse brain by
immunohistochemistry for PrP
Sc , the Japanese authorities concluded that the
published results were invalid as no spongiform change or
PrP
Sc was found on first passage from human
colostrum to mice. The brain from the second passage (mouse
to mouse) did show spongiform change and PrP
Sc but this was not attributed to transmission
from the colostrum (Prof. K Yamanouchi, personal
communication to R. Bradley February 1997, in: E.C.,
1997)
d. No mother to child CJD transmissions
have occurred in kuru or CJD and neither epidemiological
nor experimental studies have demonstrated the vertical
transmission of CJD. (There are a handful of iatrogenic CJD
cases in pregnant women who have delivered children who
remain healthy years afterward - in one case 30
years).
e. To date, no cow to calf disease
transmissions has occurred in association with BSE infected
suckler cows.
f. No excess of BSE cases in the
offspring of affected animals in the UK has been observed.
Outside the UK, no BSE has been observed so far in the
offspring of BSE cows
2.5. Research on milk.
Experiments to test milk which can use
enough volume of milk to be like the realistic situation
are difficult to devise. Currently there seem not to exist
plans to inoculate bovine milk i/c into cattle. However a
PrP study of milk from experimentally infected cattle
commissioned by the UK Food Standards Agency is planned and
about to start. A small scale study is nevertheless
presently running at the NPU (N.Hunter, personal
communication, 14.03.01
) with scrapie susceptible lambs removed from their
mothers and hand reared No results are yet available. EC
FAIR Project N°CT98-7023 looking among other things to
vertical transmission in scrapie. It is expected that it
will also foreseen to look at the colostrum and
milk.
2.6. References:
Bradley, R., 2001. Bovine milk: its safety in regard
to risks from the agents that cause transmissible
spongiform encephalopathies (TSE). Private consultancy
report provided on a confidential basis. 9pp.
DONNELLY C.A., FERGUSON N.M., GHANI A.C., WILESMITH
J.W., ANDERSON R.M., 1997b. Analysis of dam-calf pairs
of BSE cases : confirmation of a maternal risk enhancement.
Proc. R. Soc.Lond. B,
264, 1647-1656.
DONNELLY C.A., GHANI A.C., FERGUSON N.M., WILESMITH
J.W., ANDERSON R.M., 1997a. Analysis of the bovine
spongiform encephalopathy maternal cohort study : evidence
for direct maternal transmission. Appl. Statist.,
46, 321-344.
DONNELLY, C.A., 1998. Maternal transmission of BSE:
interpretation of the data on the offspring of BSE-affected
pedigree suckler cows. Vet. Rec. 142, 579-580.
E.C. (European Commission), 1997a. Report of 17 Feb
1997. from the Scientific Veterinary Committee on the risk
analysis for colostrum, milk and milk Products. Document N°
VI/8197/96 Version J (Final).
E.C. (European Commission), 1997b. Opinion of 16 May
1997 of the Multidisciplinary Scientific Committee on the
possible risks related to the use of colostrum, milk and
milk Products.
E.C. (European Commission), 1999. Opinion of 18-19
March 1999 of the Scientific Steering Committee on the
possible vertical transmission of Bovine Spongiform
Encephalopathy (BSE).
Lacey, R.W., Dealler, S.F., 1994. The transmission
of prion disease. Vertical transfer of prion disease. Human
reproduction, 9 (10): 1792-1800. Debate with contributions
from P.Brown (pp 1796-1797) and R.G.Will and J.Wilesmith
(pp 1797-1800).
MAFF, 2000. BSE: A Progress Report. June 2000. MAFF,
London.
Tamai, Y., Kojima, H., Kitajima, R., Taguchi, F.,
Ahtani, Y., Kawagichi, T., Miura, S., Sato, M., 1992.
Demonstration of the transmissible agent in tissue from a
pregnant woman with Creutzfeldt-Jakob disease. The New
England Journal of Medicine,
327 (9): 649.
TAYLOR, D.M., FERGUSON, C.E., BOSTOCK, C.J. and DAWSON,
M., 1995. Absence of disease in mice receiving milk
from cows with bovine spongiform encephalopathy. Vet Rec
136, 592.
WILESMITH J.W., WELLS G.A.H., RYAN J.B.M., GAVIER-WIDEN
D., SIMMONS M., 1997. A cohort study to examine
maternally-associated risk factors for bovine spongiform
encephalopathy. Veterinary Record, ,
141, 239-243.
WILESMITH, J.W., RYAN J.B.M., 1998. Comment on
Donnelly 1998 (see above)
Wilesmith, J.W., Ryan, J.B.M
1997. Absence of BSE in the offspring of pedigree
suckler cows affected by BSE in Great Britain. Vet.Rec.,
141, 250-251.
Will, R., 1997. Letter of 9 May 1997 to the
secretariat of the Multidisciplinary Scientific
Committee.
3. Acknowledgements:
The contributions from the following
scientists are gratefully acknowledged: Dr.R.Bradley,
Dr.P.Brown, Dr.D.Heim, Dr.N.Hunter, Dr.R.Somerville,
Prof.Dr.R.Will.
----------------------------------------
1
See also the Prof.M.Ferguson-Smith,
Cambridge University, reported on in the media of 16 January
2001.
2
These and other studies are further
reported and commented on in E.C., 1999.
3
There is no detectable infectivity in
bovine milk or mammary gland collected from
clinically-affected, natural cases of BSE following bioassay
using the i/c route in susceptible mice (MAFF Progress Report
2000). Furthermore, there is no detectable infectivity in
milk collected from clinically affected, natural cases of BSE
at early, mid or late lactation following bioassay by the i/c
or by the oral route in susceptible mice (Taylor et al
1995).
Scientific Committees
Scientific Steering Committee (former
MDSC)
Outcome of discussions
FOOD SAFETY |
PUBLIC HEALTH
|
CONSUMER
PROTECTION |
DIRECTORATE
GENERAL "HEALTH & CONSUMER PROTECTION"
|